The Miller Fisher syndrome. Review of the cases of the Santa Maria Hospital.
AbstractA benign syndrome of acute ophthalmoplegia, ataxia, and areflexia is commonly known as the Miller Fisher syndrome. It is generally believed that Miller Fisher syndrome is a type of Guillain-Barré syndrome, but several authors believe it to be a separate clinical entity caused by a central nervous system lesion. Eight patients with Miller Fisher syndrome diagnosis, admitted to our department in the last 20 years, were reviewed. Neurophysiological studies were carefully reviewed. Our patients had a clinical presentation and evolution identical to that described previously. Neurophysiological abnormalities were found in all patients and were characteristic of a sensory axonal neuropathy, with damage of the facial nerves and occasional demyelination of peripheral nerves. The pattern of abnormalities is distinct from the usual features seen in Guillain-Barré syndrome. The CT scan, MRI, and Evoked Potentials investigations in our patients did not confirm central nervous system lesion. Nevertheless we did not exclude the possibility of coexisting damage to the central nervous system in some patients, as shown in Chronic Inflammatory Demyelinating Polyneuropathy.
How to Cite
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.